Myriad Genetics
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Myriad Genetics
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
/ 
Frequently asked questions
To buy Myriad Genetics stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Myriad Genetics by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Myriad Genetics is MYGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Myriad Genetics has its primary listing on NASDAQ. You can trade Myriad Genetics with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Myriad Genetics is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Myriad Genetics as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Myriad Genetics or others.